期刊文献+

肾移植术后合并非霍奇金淋巴瘤患者的用药监护

Pharmaceutical care on a patient with non-hodgkin lymphoma after kidney transplantation
暂未订购
导出
摘要 1例59岁男性患者,肾移植术后8年,主因“发现颈部肿块2个月余”入院。入院后诊断为弥漫大B细胞淋巴瘤。临床药师参与免疫抑制剂的调整、抗肿瘤药物治疗方案的制定等,并给予患者全程药学监护。患者化疗4周期后病情评估达到完全缓解,肾功能正常。 A 59-year-old male patient who underwent kidney transplantation 8 years ago was admitted to the hospital because of neck mass for more than 2 months.After admission,he was diagnosed as diffuse large B-cell lymphoma.Clinical pharmacist assisted to adjust dose of immunosuppressive drugs,make the regimen of chemotherapy,and gave him the full-course pharmaceutical care.After 4 cycles of chemotherapy,the patient achieved complete remission and his renal function was normal.
作者 陈晨 董艳 祁健 CHEN Chen;DONG Yan;QI Jian(Department of Clinical Pharmacy,the Second Hospital of Shandong University,Jinan 250033,China;Department of Orthopaedics,the 960th Hospital of Chinese PLA,Jinan 250031,China)
出处 《中国药物应用与监测》 CAS 2021年第2期96-98,共3页 Chinese Journal of Drug Application and Monitoring
关键词 弥漫大B细胞淋巴瘤 肾移植 临床药师 药学监护 Diffuse large B-cell lymphoma Kidney transplantation Clinical pharmacist Pharmaceutical care
  • 相关文献

参考文献4

二级参考文献20

  • 1苗芸,于立新,邓文锋,付绍杰,徐健,杜传福,王亦斌,周敏捷.国内报道移植后淋巴增殖性疾病的总结分析[J].实用器官移植电子杂志,2013,1(5):276-281. 被引量:9
  • 2瞿立辉,李群,陈江华,吴建永,王逸民,张建国,王苏娅,黄洪锋,何强.肾移植患者并发恶性肿瘤临床分析[J].中华泌尿外科杂志,2004,25(7):445-447. 被引量:22
  • 3Sabattini E, Bacci F, Sagramoso C, et al. WHO classification of tumors of haematopoietic and lymphoid tissues in 2008:an over- view. Pathologica, 2010, 102:83-87.
  • 4Lister TA, Crowther D, Suteliffe SB, et al. Report of a commit- tee convened to discuss the evaluation and staging of patientswith Hodgkin' s disease: Cotswo|ds meeting. J Clin Oncol, 1989, 7:1630-1636.
  • 5Myers AM, Moore GE. A predictive model for non-Hodgkin' s lymphoma. N Engl J Med, 1994, 330: 574-575.
  • 6Cheson BD, Homing SJ, Coiffier B, et al. Report of an intemational workshop to standardize response criteria for non- Hodgkin' s lymphomas. NCI Sponsored Intemational Working Group. J Clin Oncol, 1999, 17:1244.
  • 7Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues.4nd ed. Lyon:IARC, 2008.
  • 8Morton LM, Landgren O, Chatterjee N, et al. Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Blood, 2007, 110: 4599-4605.
  • 9van Leeuwen MT, Grulich AE, Webster AC, et al. Immu- nosuppression and other risk factors for early and late non- Hodgkin lymphoma after kidney transplantation. Blood, 2009, 114:630-637.
  • 10Capello D, Cerri M, Muti G, et al. Molecular histogenesis of post-transplantation lymphoproliferative disorders. Blood, 2003, 102: 3775-3785.

共引文献190

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部